Serum CD26 is related to histopathological polyp traits and behaves as a marker for colorectal cancer and advanced adenomas
<p>Abstract</p> <p>Background</p> <p>Serum CD26 (sCD26) levels were previously found diminished in colorectal cancer (CRC) patients compared to healthy donors, suggesting its potential utility for early diagnosis. Therefore we aimed to estimate the utility of the sCD26...
Main Authors: | Páez de la Cadena María, Martínez-Ares David, Cordero Oscar J, Rodríguez-Berrocal Francisco J, Rodríguez-Piñeiro Ana M, De Chiara Loretta |
---|---|
Format: | Article |
Language: | English |
Published: |
BMC
2010-06-01
|
Series: | BMC Cancer |
Online Access: | http://www.biomedcentral.com/1471-2407/10/333 |
Similar Items
-
Postoperative serum levels of sCD26 for surveillance in colorectal cancer patients.
by: Loretta De Chiara, et al.
Published: (2014-01-01) -
CD26-Related Serum Biomarkers: sCD26 Protein, DPP4 Activity, and Anti-CD26 Isotype Levels in a Colorectal Cancer-Screening Context
by: Loretta De Chiara, et al.
Published: (2020-01-01) -
Association of Gallbladder Polyp with the Risk of Colorectal Adenoma
by: Jung Won Jeun, et al.
Published: (2014-01-01) -
Soluble CD26 Levels and Its Association to Epidemiologic Parameters in a Sample Population
by: Loretta De Chiara, et al.
Published: (2009-01-01) -
Value of Serum NEUROG1 Methylation for the Detection of Advanced Adenomas and Colorectal Cancer
by: Olalla Otero-Estévez, et al.
Published: (2020-06-01)